Predicting outcome for high-dose IL-2 therapy in cancer patients
Tuesday, December 3, 2013 - 00:00
in Health & Medicine
Previous studies indicate that regulatory T cell (Treg) populations increase in patients undergoing HD IL-2 therapy. Researchers now report on their study that performed an in depth analysis of Treg populations in melanoma patients undergoing HD IL-2 therapy.